RxDoctor Payments DataLook up a doctor →

Alan Lumsden, MD

Vascular Surgery · Houston, TXNPI 1649350042

Payments from drug & device makers

$2,367,583in general payments, 2019–2025

Across 1,183 payments — averaging $2001.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$1.5M
  • Corindus Inc.$490K
  • Endologix LLC$117K
  • W. L. Gore & Associates, Inc.$104K
  • Boston Scientific$43K
  • Cook Research Incorporated$12K
  • plus $62K from 54 others
$7,204in research payments, 2019–2025

Across 11 payments — averaging $654.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$7K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,367,583 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas

Medicare billing

Part B allowed, 2024
$75,571
Medicare patients
172
Services billed
286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →